The melanocortin 4 receptor agonist setmelanotide is now FDA approved for weight management in adults and children with ...
LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 17 scientific posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting (March 27-31, Denver, ...
Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in atopic ...
Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific ...
8h
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
T he recent reimbursement of Bimzelx (bimekizumab) in Ireland represents an important step forward in access to treatment for people living with immune-mediated diseases, includin ...
New interim data from the KONFIDENT-KID trial evaluating sebetralstat in children aged 2-11 accepted for late-breaking oral presentationFRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS ...
Migraine Again on MSN
Status migrainosus: How to get relief when a migraine attack won’t quit
You don’t have to suffer an endless migraine attack. Learn the signs of status migrainosus, what treatments can break the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results